Vir Biotechnology Presents New Data Evaluating the
– Data from two ongoing clinical trials in people living with chronic hepatitis B infection suggest the combination of an antiviral with an immunomodulator...
Source: globenewswire.com
Page 5 - Poster Presentations News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Poster Presentations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Poster Presentations Today - Breaking & Trending Today
National Association of Neonatal Therapists (NANT) Announces Call for Abstracts for Annual NANT Conference
NANT is now accepting abstract submissions for Oral and Poster Presentations for the NANT 14 Conference April 11-13, 2024, in Florida.
Source: einnews.com
Teva Presents Real-World Data for AUSTEDO® (deutetrabenazine) Tablets with 4-Week Patient Titration
START study provides real-world data for AUSTEDO with the use of a 4-week patient titration kit for adults with tardive dyskinesia (TD), including utilization and patient satisfactionAUSTEDO is the only vesicular monoamine transporter 2 (VMAT2) inhibitor with 3-year long-term data1,2 approved for adults with TD and...
Source: pharmiweb.com
Teva Presents Real-World Data for AUSTEDO® (deutetrabenazine) Tablets with 4-Week Patient Titration Kit at Psych Congress Elevate 2023
START study provides real-world data for AUSTEDO with the use of a 4-week patient titration kit for adults with tardive dyskinesia , including utilization and patient satisfaction AUSTEDO is the... | June 10, 2023
Source: marketscreener.com
AACR 2023 | Ascentage Pharma Presents Results from Three Studies Underscoring Exploratory Efforts in Potential New Indications
/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...
Source: prnewswire.com